Figure 5: HA Versus TD Plots for Pre/Post Scans for the CDC

The calculated HAT (slope of the HA vs. TD line plot) did not significantly change in the treated group (−1.01°/%TD to −0.98°/%TD). In contrast, the placebo group exhibited a significant (p = 0.03) reduction in HAT (−1.03°/%TD to −0.88°/%TD) between the pre/post scans indicating an overall loss in helix transmurality. Furthermore, HA was significantly (p = 0.03 and p = 0.04, respectively) different at 10% and 30% TD between pre/post scans, with 90% TD trending toward significance (p = 0.08). Abbreviation as in Figures 1 and 3.